LFVN — Lifevantage Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual income statement for Lifevantage, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	233	220	206	213	200
Cost of Revenue
Gross Profit	195	182	168	170	159
Selling / General / Administrative Expenses
Unusual Expense / Income
Total Operating Expenses	217	203	201	209	196
Operating Profit	15.5	17.6	5.37	4.26	4.33
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	14.7	17.2	4.69	4	4.35
Provision for Income Taxes
Net Income After Taxes	11.5	12.9	3.12	2.54	2.94
Net Income Before Extraordinary Items
Net Income	11.5	12.9	3.12	2.54	2.94
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	11.5	12.9	3.12	2.54	2.94
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.791	0.945	0.351	0.222	0.226
Dividends per Share
Special Dividends per Share